OMC
EBAC

Old Mission Capital’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

Old Mission Capital’s Portfolio EBAC Stock Details EBAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,425
Closed – – 1860
2022
Q3 		$0 Buy
+14,425
New +$142K ﹤0.01% 1525

Other funds holding EBAC

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Old Mission Capital's EBAC Position: Q4 2022 in Review

Old Mission Capital sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q4 2022, closing a stake of 14,425 shares.

Old Mission Capital first reported a position in EBAC in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 50 funds tracked by Wall St. Rank hold EBAC as of Q4 2022.

  • Old Mission Capital reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Old Mission Capital sold 14,425 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q4 2022.
  • Old Mission Capital first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q3 2022 and held it in 1 quarter.
  • Old Mission Capital's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $0 in Q3 2022.
  • 50 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q4 2022.

Based on Old Mission Capital's 13F filing for Q4 2022, filed 14 Feb 2023.